Stroke
News
Seeking Breakthroughs: The Industry Perspective
September 2018—A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCB
Seeking Breakthroughs—We Want You!
Shamik Bhattycharyya, MD, MS
September 2018—The challenges we must overcome to find breakthrough treatments in neurology are many and the potential is great.
Intrathecal Baclofen More Effective Than Oral Medication for Treating Pain in Patients With Poststroke Spasticity
Thursday, August 16, 2018—Results from the SISTERS trial (NCT01032239) show that intrathecal administration (ITB Therapy; Medtronic, Dublin, Ireland) of baclofen (Lioresal Intrathecal; Saol Therapeutic…
First Patient Enrolled in Phase 3 Study of Athersys’ Stem Cell Treatment for Patients who Experienced Ischemic Stroke
Wednesday, August 01, 2018—The first patient has been enrolled in a phase 3 study, MASTERS-2 (NCT03545607), which is a pivotal study that has received special protocol assessment, fast-track designation…
Aggressive Treatment of Hypertension Promotes Healthy Brains and Hearts
Monday, July 30, 2018—Aggressive lowering of systolic blood pressure (BP) reduces the risk of mild cognitive impairment (MCI) and combined MCI and dementia. In the SPRINT trial (NCT01206062), 2 str…
Breaching the Blood-Brain Barrier: A Potential New Treatment Modality
Monday, July 30, 2018—In a small, yet groundbreaking, clinical trial, MR-guided focused ultrasound (MRgFUS) (ExablateNeuro; Insightec, Miami FL) was used to open the blood-brain barrier (BBB) safel…
Every Minute Counts in Treating Stroke
Thursday, July 26, 2018—The Society of NeuroInterventional Surgery (SNIS) announced findings from a study using a Markov model of lifetime quality-adjusted life years (QALYs) in patients treated with…
First Patients Treated With Next-Generation Embotrap II Stent Retriever
Wednesday, July 25, 2018—Cerenovus, part of the Johnson & Johnson Medical Devices Companies, announced the launch of its Embotrap II revascularization device at the Society of NeuroInterventional …
